Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,307,135
in 1 filing, $6.3M under 10b5-1 plans

Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kewalramani Reshma −$6.3M CEO & President sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-27 ALTSHULER DAVID EVP, Chief Scientific Officer Sale 10b5-1 −1,272 $480.00 $611K 32,974
2025-02-26 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −4,962 $479.61 $2.4M 54,969
2025-02-26 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes 10b5-1 −4,962 $479.61 $2.4M 59,069
2025-02-26 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −3,703 $479.61 $1.8M 68,490
2025-02-26 Kewalramani Reshma CEO & President Shares withheld for taxes −14,079 $479.61 $6.8M 105,915
2025-02-26 Bozic Carmen EVP and CMO Shares withheld for taxes −4,962 $479.61 $2.4M 32,669
2025-02-26 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Shares withheld for taxes 10b5-1 −2,482 $479.61 $1.2M 22,002
2025-02-26 Arbuckle Stuart A EVP, COO Shares withheld for taxes −7,071 $479.61 $3.4M 62,935
2025-02-26 Ambrose Kristen SVP & Chief Accounting Officer Shares withheld for taxes −1,241 $479.61 $595K 7,845
2025-02-26 ALTSHULER DAVID EVP, Chief Scientific Officer Shares withheld for taxes 10b5-1 −5,954 $479.61 $2.9M 34,246
2025-02-25 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −354 $480.95 $170K 64,031
2025-02-25 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Sale 10b5-1 −1,767 $480.95 $850K 24,484
2025-02-25 Ambrose Kristen SVP & Chief Accounting Officer Sale 10b5-1 −884 $480.95 $425K 9,086
2025-02-25 ALTSHULER DAVID EVP, Chief Scientific Officer Sale 10b5-1 −848 $480.95 $408K 40,200
2025-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −3,310 $483.28 $1.6M 59,931
2025-02-24 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes 10b5-1 −3,310 $483.28 $1.6M 64,385
2025-02-24 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes −2,470 $483.28 $1.2M 72,193
2025-02-24 Kewalramani Reshma CEO & President Shares withheld for taxes −9,386 $483.28 $4.5M 119,994
2025-02-24 Bozic Carmen EVP and CMO Shares withheld for taxes −3,310 $483.28 $1.6M 37,631
2025-02-24 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Shares withheld for taxes 10b5-1 −1,656 $483.28 $800K 26,251

Page 14 of 18 · 344 trades